Pharmacological characterization of GPR55, a putative cannabinoid receptor
about
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsEndocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceAM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studiesPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsGPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination.The natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonistsEndocannabinoid-mediated synaptic plasticity and addiction-related behaviorThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth.Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy.Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease.Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeysPromising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionEndocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.Cannabinoid receptors: nomenclature and pharmacological principlesCannabinoid modulation of neuroinflammatory disorders.The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α.Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice.Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitroDeletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain SensationThe cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRαDesign, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-onesModulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.A potential role for GPR55 in gastrointestinal functionsDifferential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.The multiplicity of action of cannabinoids: implications for treating neurodegeneration.Off-target cannabinoid effects mediated by GPR55.Is there any clinically relevant cannabinoid-induced analgesia?Cannabinoids: novel therapies for arthritis?Endocannabinoid modulation of dopaminergic motor circuits.Molecular Pharmacology of Phytocannabinoids.The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
P2860
Q24605072-E3B7726E-AD98-4F83-8B5D-FDE493C2DDD6Q26739831-C8B6FFE6-CDA8-4931-B522-639D9502B036Q28270589-5D25339F-5100-4BE6-84DB-C5AA66DB00F9Q28286551-B8204C1E-D2E5-4804-B7E9-BEF3BA9BEFA3Q28508581-12D3728F-5A8B-4EE7-9E16-C8FB44CA558BQ28534752-633E294B-3EC8-4A00-8EE3-9F358793659FQ29042501-30AF55F7-1F9B-4E4C-9FCF-B0A350F94070Q30486707-614CF518-6F1E-4F0B-BB7A-DB493BC423B8Q33636763-DBCD92F3-BA90-4690-B1AA-E07719F73C6CQ34264328-E04292B0-BF08-45DE-A7FF-AD2492332A00Q34471868-4CD34282-314F-4AC5-AA60-3A32D8FD23EDQ34659846-A9D63524-04A0-4357-A3C1-0434C8B8C626Q34664067-3B66D421-CE6E-400E-967C-1C49AD8A0EB7Q35052556-55949D29-FB3D-4E64-ACFC-1B70D2AB9287Q35094180-04313A8E-6892-452E-82FC-D47D0E947DB6Q35287465-DBC6736A-91D0-41EE-8FD6-64A3712F92B4Q35499568-379158ED-E959-4DB0-B3CD-264170B93226Q35532072-7A0263F0-9273-43A8-B44B-42DE457A2CC5Q35602343-24589AC9-290E-432B-B1B2-698D761738F6Q35672413-AF6184B8-29A8-45CD-8A8D-71FF6F2A0755Q36044310-B545EC89-C3C5-42EF-93FC-CF0A56275520Q36067324-11A3868B-98BF-4DB0-98F8-1B5A961C121EQ36127141-9806D9DE-16AC-4B9F-84EC-5161D52BA1BCQ36166294-7E88273C-5876-4215-9819-66CAB9368CCDQ36176547-CF6386E8-9DE2-4769-A7B3-3FD00652A5B7Q36219994-9F21A41C-24D0-4B7F-8075-3EE03E398E72Q36492788-0DE58968-FC3C-4D9A-9E9D-B5FB5A3820D7Q36497790-94D71823-3C93-42A0-836F-2BF88D36BAFEQ36811111-F4E7AE67-62BC-425B-BF46-1578222C76BEQ36843205-858DA813-A951-4BC9-BACE-19B0B9720899Q36864469-C6FFC858-7140-49C8-BB27-12AE2FC5560DQ37192334-B3E3F1C5-5976-42C5-8D09-352292550CDCQ37793366-05D1DFCD-DCB0-44B0-9F7E-6E77B57B8095Q37995375-490609F0-B6A0-498F-AB6B-B4B9F5F38E47Q38003023-0468CBEB-DBA1-4859-907C-71EC8A7255BFQ38005189-21B3CEC7-77C4-4E13-8313-6C44D3117985Q38018946-3DC11218-122F-4DCF-BDEB-90082F1C2B5DQ39102188-C96AF34E-FFE2-459C-B11D-AF0400A1E487Q39274311-1A06EDC9-B777-498A-BBF4-6DD3CBD7D314Q39432376-213B68D7-660E-498C-BF53-345F4EA6668A
P2860
Pharmacological characterization of GPR55, a putative cannabinoid receptor
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacological characterization of GPR55, a putative cannabinoid receptor
@ast
Pharmacological characterization of GPR55, a putative cannabinoid receptor
@en
type
label
Pharmacological characterization of GPR55, a putative cannabinoid receptor
@ast
Pharmacological characterization of GPR55, a putative cannabinoid receptor
@en
prefLabel
Pharmacological characterization of GPR55, a putative cannabinoid receptor
@ast
Pharmacological characterization of GPR55, a putative cannabinoid receptor
@en
P2860
P921
P1476
Pharmacological characterization of GPR55, a putative cannabinoid receptor
@en
P2093
Haleli Sharir
Mary E Abood
P2860
P304
P356
10.1016/J.PHARMTHERA.2010.02.004
P577
2010-03-16T00:00:00Z